NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/24/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization639.14 mln
Float66.02 mln
Earnings Date11/11/2026
EPS
2.18
Solid
P / E
3.80
Deeply undervalued
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
17.62
Highly suspicious
1-Year Forecast
15.40
Transformational upside
Relative Strength
95
/ 100
Top performer
Business Description
CorMedix is a New Jersey-based medical company working to protect seriously ill patients from dangerous infections. Its flagship product, DefenCath, is a solution used to clean and seal dialysis catheters, helping to prevent life-threatening bloodstream infections in people with kidney failure. The company has been operating under its current name since 2007.
